OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial

OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial

Bibliographic Details
Main Authors:	Wechsler, M, Akuthota, P, Jayne, D, Khoury, P, Klion, A, Langford, C, Merkel, P, Moosig, F, Specks, U, Cid, M, Luqmani, R, Brown, J, Mallett, S, Philipson, R, Yancey, S, Steinfeld, J, Weller, P, Gleich, G
Format:	Conference item
Published:	BMJ Publishing Group 2017

Similar Items

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
by: Wechsler, M, et al.
Published: (2017)

Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
by: Wechsler, M, et al.
Published: (2017)

Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
by: Benjamin Terrier, et al.
Published: (2023-07-01)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
by: Falk, R, et al.
Published: (2011)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
by: Falk, R, et al.
Published: (2011)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
by: Falk, R, et al.
Published: (2011)

Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis
by: Falk, R, et al.
Published: (2011)

Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
by: Giuseppe A. Ramirez, et al.
Published: (2022-12-01)

Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis
by: Jessy Chen, et al.
Published: (2023-06-01)

Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis
by: Moriyasu Anai, et al.
Published: (2022-04-01)

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
by: Masanobu Ueno, et al.
Published: (2021-03-01)

Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
by: Charlene Desaintjean, et al.
Published: (2024-03-01)

Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings
by: Takaharu Ikeda, et al.
Published: (2023-08-01)

The effects of mepolizumab on peripheral circulation and neurological symptoms in eosinophilic granulomatosis with polyangiitis (EGPA) patients
by: Noboru Kitamura, et al.
Published: (2021-01-01)

Efficacy and safety of belimumab in combination with azathioprine for remission maintenance in granulomatosis with polyangiitis and microscopic polyangiitis: a multicenter randomized, placebo-controlled study
by: Jayne, D, et al.
Published: (2017)

Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics
by: David R.W. Jayne, et al.
Published: (2024-01-01)

Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis
by: Nami Masumoto, et al.
Published: (2023-05-01)

An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
by: Sujit Surendran, et al.
Published: (2017-01-01)

Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
by: Andrea Portacci, et al.
Published: (2023-10-01)

Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation
by: Mari Sato, et al.
Published: (2023-01-01)

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
by: Masanobu Ueno, et al.
Published: (2022-06-01)

A MODEL TO PREDICT CARDIOVASCULAR EVENTS IN PATIENTS WITH NEWLY DIAGNOSED WEGENER'S GRANULOMATOSIS AND MICROSCOPIC POLYANGIITIS
by: Suppiah, R, et al.
Published: (2011)

Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.
by: Merkel, P, et al.
Published: (2005)

Granulomatosis with polyangiitis
by: Zubayer Ahmad, et al.
Published: (2016-12-01)

Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
by: Christian Dejaco, et al.
Published: (2015-01-01)

Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis.
by: Rennie L Rhee, et al.
Published: (2018-01-01)

Reduction in ANCA levels associated with mepolizumab add-on treatment in eosinophilic granulomatosis with polyangiitis: Case series and literature review
by: Yosuke Kamide, et al.
Published: (2024-01-01)

Eosinophilic granulomatosis with polyangiitis: sequential use of mepolizumab following rituximab for inadequate asthma control despite vasculitis remission
by: B. Cremonezi Lammoglia, et al.
Published: (2023-12-01)

Improvement of peripheral neuropathy in a patient with antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis by additional mepolizumab
by: Yoshiro Kai, et al.
Published: (2022-02-01)

A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
by: Michele V. Quan, et al.
Published: (2018-11-01)

Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis
by: Kasia Owczarczyk, et al.
Published: (2020-09-01)

Granulomatosis with polyangiitis in Tunisia
by: I. Ben Ghorbel, et al.
Published: (2017-05-01)

The use of ECMO in pediatric granulomatosis with polyangiitis
by: Rachel Finkel, et al.
Published: (2022-05-01)

Long-term surveillance study of rituximab originator treated patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA)
by: Uchida, L, et al.
Published: (2024)

A model to predict cardiovascular events in patients with newly diagnosed wegener's granulomatosis and microscopic polyangiitis.
by: Suppiah, R, et al.
Published: (2011)

A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis.
by: Suppiah, R, et al.
Published: (2011)

Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis
by: Masayoshi Harigai, et al.
Published: (2019-05-01)

Ocular Involvement of Granulomatosis with Polyangiitis
by: Anna Byszewska, et al.
Published: (2023-07-01)

Meningeal involvement in granulomatosis with polyangiitis
by: Andreia Brito, et al.
Published: (2023-04-01)

Digital Necrosis in Granulomatosis with Polyangiitis
by: Philipp Jud, et al.
Published: (2023-01-01)